Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Cancer Medicine|September 7, 2022
KRAS mutated Non-Small Lung Carcinoma: A Real World Context from the Indian subcontinentUllas Batra, Shrinidhi Nathany, Mansi Sharma, et al.South Asian Journal of Cancer|December 31, 2025
Spectrum of Resistance Mechanisms to ALK TKIs in NSCLC: Largest Single-Center Experience from IndiaUllas Batra, Shrinidhi Nathany, Mansi Sharma, et al.Immunotherapy|June 14, 2022
Immunotherapy in advanced non-small-cell lung cancer (NSCLC) after progression on chemotherapy: real-world results from a prospective institutional cohortUllas Batra, Kundan Singh Chufal, Shrinidhi Nathany, et al.Lung India : Official Organ of Indian Chest Society|October 23, 2025
Circulating tumour DNA as a predictive biomarker for tumour response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancerUllas Batra, Mansi Sharma, Shrinidhi Nathany, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|September 19, 2025
Coexistence of IDH1 Mutation and KIAA1549::BRAF Fusion in a Diffuse Glioma: A Case Report With Clinical, Radiological, and Pathological CorrelationSumanta Das, Sunita Ahlawat, Shrinidhi Nathany, et al.Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|August 14, 2024
VCL::ROS1: A Novel ROS1 Oncogenic Fusion Detected on Next Generation SequencingAnurag Mehta, Himanshi Diwan, Shrinidhi Nathany, et al.Neuropathology : Official Journal of the Japanese Society of Neuropathology|June 1, 2025
Pituitary Blastoma: Expanding the Spectrum of Histopathological Findings in a Young Adult With DICER1 MutationSumanta Das, Bheru Dan Charan, Shrinidhi Nathany, et al.Journal of Cancer Research and Therapeutics|July 20, 2023
Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entitySunil Pasricha, Ankush Jajodia, Anila Sharma, et al.Leukemia Research Reports|July 13, 2026
Rare CNS manifestation of high-risk CLL with excellent response to triplet targeted therapyAnusha Swaminathan, Shrinidhi Nathany, Surbhi Singh, et al.Discover Oncology|March 8, 2025
Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspectiveUllas Batra, Ajay Kumar Singh, Shrinidhi Nathany, et al.Pageof 4